Pacira BioSciences, Inc.

PCRX • NASDAQ

Pacira BioSciences, Inc. is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Frank D. Lee, with a market cap of $997.7M.

Market Cap$997.7M

Employees712.0

CEOFrank D. Lee

CountryUnited States of America

Healthcare

Drug Manufacturers - Specialty & Generic

Next EarningsApr 30, 2026 · In 1 weekAfter Market Close · Q1 2026

Income Statement Balance Sheet Cash Flow Business Segments

Financials

View all metrics

Pacira BioSciences, Inc. FAQ

Common questions about Pacira BioSciences, Inc.

Pacira BioSciences, Inc. is scheduled to report earnings for Q1 2026 on April 30, 2026 after market close. Analysts estimate revenue of $171.8M.

Pacira BioSciences, Inc. has approximately 712 employees.

Pacira BioSciences, Inc.

Financials

Revenue

Net Income

Operating Cash Flow

EPS (Diluted)

Pacira BioSciences, Inc. FAQ

When is Pacira BioSciences, Inc.'s next earnings date?

How many employees does Pacira BioSciences, Inc. have?

Cookie Preferences